Results 31 to 40 of about 37,026 (217)

The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder

open access: yesBrain and Behavior, 2020
Background Pharmacodynamics and pharmacogenetics are being explored in pharmacological treatment response for major depressive disorder (MDD). Interactions between genotype and treatment response may be dose dependent.
Jay Fawver   +4 more
doaj   +1 more source

Galactorrhoea as a side effect due to Bupropion- a case report

open access: yesEuropean Psychiatry, 2021
Introduction Bupropion is a NDRI antidepressant with action on both serotonin and nicotinic receptors. Endocrine and sexual adverse effects are very rare and hence very unlikely to cause hyperprolactinemia.
D. Bhandutia, S. Nayok
doaj   +1 more source

Bupropion administration increases resting-state functional connectivity in dorso-medial prefrontal cortex [PDF]

open access: yes, 2017
Background: Patients on the selective serotonergic re-uptake inhibitors (SSRI) like citalopram report emotional blunting. We have shown previously that citalopram reduces resting-state functional connectivity (RSFC) in healthy volunteers in a number of ...
Dean, Zola   +2 more
core   +1 more source

Nicotine addiction : a review [PDF]

open access: yes, 2013
Nicotine, the major psychoactive compound in tobacco, acts as a potent addictive drug in humans. The addictive nature of nicotine leads to more than 6 million deaths a year.
Di Giovanni, Giuseppe, Vella, Jacob
core   +1 more source

Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose

open access: yesArchives of Epilepsy, 2018
Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack
Zeynep ÖZÖZEN AYAS   +1 more
doaj   +1 more source

Buprenorphine added on brief cognitive behavioral therapy for treatment of methamphetamine use disorder [PDF]

open access: yes, 2018
Background: Methamphetamine (MA) use remains a major public health concern around the world. Recent findings suggest that buprenorphine may be helpful for cocaine use reduction. Moreover, animal studies described reduced dopamine peak effect following MA
Dean AJ   +10 more
core   +1 more source

Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones [PDF]

open access: yes, 2017
Synthetic cathinones are a new class of psychostimulant substances. Rarely, they can cause liver injury but associated mechanisms are not completely elucidated.
Krähenbühl, Stephan   +2 more
core   +1 more source

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial. [PDF]

open access: yes, 2020
BackgroundSmoking rates are high in adults with anxiety disorders (ADs), yet little is known about the safety and efficacy of smoking-cessation pharmacotherapies in this group.MethodsPost hoc analyses in 712 smokers with AD (posttraumatic stress disorder
Anthenelli, Robert M   +6 more
core  

Abnormal Uterine Bleeding Associated with Bupropion: A Case Report

open access: yesBagcilar Medical Bulletin, 2022
In the literature, many cases of abnormal uterine bleeding associated with selective serotonin reuptake inhibitors have been reported as a side effect of antidepressant treatment.
Melek Kanarya Vardar, Evrim Ebru Kovalak
doaj   +1 more source

Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI

open access: yesCase Reports in Psychiatry, 2015
Bupropion hydrochloride (HCI) is an antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor and has three different dosage forms including immediate release (IR), sustained release (SR), and extended release (ER).
Filiz Izci   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy